Stampacchia Otello insider trades
Stampacchia Otello has filed 8 Form 4s with the SEC that we hold, for ImageneBio, Inc. (IMA) (Director), KRON (Director) and Replimune Group, Inc. (REPL) (Director, 10% owner). Across all of them we count 1 purchase worth $8.0M and 1 sale worth $408.7K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 267,556 shares of ImageneBio, Inc. worth $8.0M, dated 2025-07-25. The first filing on our record is dated 2021-09-27 and the latest 2026-06-18.
ImageneBio, Inc. (IMA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-07-25 | P, purchase reported on Form 4 | 267,556 | $8.0M | 2025-07-30 | SEC |
KRON
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Replimune Group, Inc. (REPL)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-23 | S, sale reported on Form 4 | 12,171 | $408.7K | 2021-09-27 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1361712) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
